Tetrabenazine Racemate 7730 for 12 months

for 12 months

2C9 and 2D6) and in each case the IC50 is more than 30 µM

2017 Jun 2

USP1-UAF1 could be a key regulator of the DNA damage response and a target for overcoming resistance to the platinum-based anticancer drugs

PF01367338 phosphate

Tetrabenazine Racemate 7730 for 12 monthsTetrabenazine Racemate (Ro 1 9569 Racemate) is a selective and reversible inhibitor of vesicular monoamine transporter 2 (VMAT 2).(1) The reference for administration is 0. 25 0. 75 mg kg IP(2) Injections of tetrabenazine into accumbens core also reduced FR5 lever pressing and increased chow intake. (3) Tetrabenazine (Racemate) reduced extracellular DA and altered DARPP 32 signaling in both substance P and enkephalin containing accumbens neurons. (4)